Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 July 2019 | Story Ruan Bruwer | Photo Tania Allen
Tanya von Berg
Tanya von Berg has represented the UFS netball team with distinction over seven years, winning three Varsity Netball titles and one USSA crown.

Although she did not quite reach her final goal in a Kovsie netball dress, being honoured one last time brought much peace to Tanya von Berg.

She was named in the Dream Team at the conclusion of the University Sport South Africa (USSA) tournament in Johannesburg and was thus recognised as the best centre at the competition.

According to the stalwart who played in her seventh year for the University of the Free State, her goal was to make this team and lift the trophy. The team didn’t succeed in the latter, losing to the North-West University in the semi-final.

Heading abroad
“Knowing that it would be the last time I would be playing for the team, I set myself these two goals. Although we were not able to claim the title, at least making the Dream Team helped to make me feel that I finished on a high, giving my all one last time,” she said.

Von Berg, who is doing her honours in Education this year, received a teaching post in Qatar, where she will start in August.

Remarkably this versatile player, who could play any one of four positions, only missed two matches in the two student competitions since making her debut as a first-year student in 2013. This was due to national commitments in 2016 (playing for South Africa A) and her honeymoon last year.

Standout moments
“Being named for the Protea training squad in 2016 and being selected for the national Fast5 team later that year, was the two outstanding moments of my career.”
“What I remember about my first year, was how huge it was to play with the seniors. The one player who served as my biggest inspiration, was Isélma Parkin. She didn’t receive the recognition she deserved. I learned from her to continue to work hard and to never give up.”


News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept